
Z-Gly-Gly-Arg-AMC
CAS No. 66216-78-2
Z-Gly-Gly-Arg-AMC( —— )
Catalog No. M30497 CAS No. 66216-78-2
Z-Gly-Gly-Arg-AMC is a thrombin-specific fluorogenic substrate for testing of thrombin generation in PRP and platelet-poor plasma (PPP).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 85 | Get Quote |
![]() ![]() |
10MG | 122 | Get Quote |
![]() ![]() |
50MG | 356 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameZ-Gly-Gly-Arg-AMC
-
NoteResearch use only, not for human use.
-
Brief DescriptionZ-Gly-Gly-Arg-AMC is a thrombin-specific fluorogenic substrate for testing of thrombin generation in PRP and platelet-poor plasma (PPP).
-
DescriptionZ-Gly-Gly-Arg-AMC is a thrombin-specific fluorogenic substrate for testing of thrombin generation in PRP and platelet-poor plasma (PPP).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66216-78-2
-
Formula Weight579.6
-
Molecular FormulaC28H33N7O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Z-Gly-Gly-Arg-AMC
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
neo-gambogic acid
Neogambogic acid an active ingredient in garcinia can inhibit the growth of some solid tumors and result in an anticancer effect it may be responsible for the inhibition of proliferation of human breast cancer cell line MCF-7 cells.
-
Flucycloxuron
Flucycloxuron is a chitin synthesis inhibitor used as a pesticide. In insect models, the inhibitor has been shown to affect several reproductive events such as the duration of preovipostion.
-
GPLGIAGQ TFA(109053-...
GPLGIAGQ TFA, is an MMP2-cleaved polypeptide that is used as a stimulus-sensitive connector in both liposomes and micelle nanoceroses for targeted therapy of tumors triggered by MMP2.